Weekly hotline Update #22 – 04-23-07
* The May Monthly Report will be sent Tuesday in place of the
Weekly Hotline Update:
Earnings continue to come through strong and stocks are
responding favorably. That is key for as long as the market
continues responding well to good news the rally should
continue on a near-term basis. The indices have come a long way
in April and the action bodes well looking forward into the
summer months. In this environment, the kind of stocks we
follow with the best earnings and relative strength will
continue leading the way higher.
From a broad view point, we saw a mild correction in early
March. It was dramatically sharp but it was also remarkably
short lived. Since the low the rally has also been dramatic,
and on the PRS Time Plane we have a recent example of similar
action to use as a guide post looking forward. In late 2005 the
market dipped and then rallied strongly with the S&P 500
pushing to a new high. The time period is boxed in the chart
below. Notice how the PRS_3-90 (blue) line flattened out after
the initial surge higher. I expect similar behavior in the
weeks ahead.
The correction in 2007 was extremely brief in terms of time.
Because of the brevity our favorite metric, the PRS_3-90 line,
didn’t have time to fall down in to the ideal buy zone of about
15%. However, during the rally the PRS_3-90 metric has improved
with the market. This is where the historical comparison comes
in handy. Notice how the PRS_3-90 line moved higher then went
flat for a time, as did the S&P 500. This is more or less what
are expectations are for the next few weeks. After the big run
the major indices should need some time to consolidate and
digest the big gains. Then we should additional upside
performance return, as we move into the summer months.
During the consolidation period we should see a little bit of
a shake out as investors shift from buying just about
everything to focusing on the best stocks. And, as more and
more investors start chasing the best stocks, they should
demonstrate the kind of out performance we always look for. So,
while the market may consolidate for a few weeks the prospects
for strength into the summer months remains vibrant with the
stronger stocks should demonstrating solid performance.
New Stocks
Over the past week seven stocks reached our entry criteria:
PHRM, ASIA, ITMN, ITC, CHL, IBN, and MGM.
CHL (China Mobile Ltd Adr) is a Hong Kong based
provider of wireless voice/data services in 31 provinces,
regions and municipalities in Mainland China. We have all heard
of the incredible growth in China and this is a direct play on
continued growth in China. With an IBD EPS rank of 86, CHL has
proven its ability to grow at a solid and steady rate. The
stock peaked in February and it has been consolidating since
between about 43 and 47 and is now showing strength.
With a push higher over the past week it managed to break its
primary down trend when it moved above the $46 level. CHL is
positioned to continue its upward strength. We are adding CHL
to the Aggressive Portfolio
ASIA (Asiainfo Holdings Inc) is a leading Chinese
provider of software and IT security products for the
telecommunications operators in China. Like most of the strong
China plays, they are showing great results are aided by a
thriving Chinese economy. They continue to announce new
contracts and business deals indicating a thriving business.
ASIA reports earning on Wednesday morning before the market
opens.
Like most Chinese stocks, it peaked in early February and
corrected sharply. More importantly, it is recovering very
quickly and with some help from a healthy earrings report
Wednesday evening, it should continue it impressive price
performance.
MGM (MGM Mirage Inc) operates 23 casinos including the
famous MGM Mirage hotel and casino in Las Vegas, along with
several other very well known resorts along the Las Vegas
Strip. IBES Earnings: 2006a $2.06; 2007e $$2.36; 2008e $2.74.
MGM has an IBD EPS ranking of 95, which tells us the company is
very strong when it comes to its earnings record.
MGM peaked like many in February and has consolidated at a
high level. The fall off of its (Red) 3-month PRS line is due
to the stock consolidating sideways rather than the price
falling, which is considered a healthier setup. MGM broke the
obvious down trend line and is clearly working higher, though
still within a consolidation formation.
IBN (Icici Bank Ltd Ads) is an India bank providing
banking and financial services to corporate and retail
customers, including commercial banking, investment banking,
and insurance. IBES Earnings: 2006a $1.38; 2007e $1.70; 2008e
$2.10. IBN has an IBD EPS ranking of 83. The solid EPS ranking
in conjunction with the strong earnings estimates indicates a
well established company with excellent forward looking
prospects.
IBN is also in the recovery process. The main factor is it has
broken its most obvious down trend line from its consolidation,
and it is in a clear healthy up trend. Seeing IBN fall back
below the 39 – 40 level would be discouraging, but the main
focus is maintaining the uptrend.
ITC (I T C Holdings Corp) is engaged in the
transmission of electricity to local distribution facilities
from generating stations. ITC has an IBD EPS ranking of 68.
According to IBES: 2006a
ITMN (Intermune Inc) is a biopharmaceutical company
focused on developing and commercializing innovative therapies
in the pulmonology and hepatology, for the treatment of lung
conditions and liver disorders. With negative earnings
estimates, this is a biotechnology drug play. Recently we have
seen a rush into this area as investors search for the next big
drug. I personally am not a big fan of betting on FDA approval.
When these types of stocks work, they payoff can be huge, but
the risk of FDA rejection is tremendous. This is viewed as a
very high risk stock.
PHRM (Pharmion Corp) focuses on acquiring developing
and commercializing innovative products for the treatment of
hematology and oncology patients. On March 22 PHRM presented
favorable data for one of their developmental products. The
company actually made money in 2005, but according to IBES
earnings estimates, the company is not expected to return to
profitability until 2009. Of course, with a drug company, that
could change at any time. Again, the potential payoff for
biotech drug companies is huge; however, the risk of FDA
rejection is tremendous. This is viewed as a very high risk
stock.
Stocks that look Attractive at this time: ANST
(Ansoft); IGLD (Internet Gold-Golden); PSMT (Pricesmart Inc);
GROW (US Global Investors Inc) consolidating strong run higher;
CLB (Core Laboratories) is positioned to make new highs after
reporting strong earnings; CVO (Cenveo); ANAD (Anadigics Inc)
positioned for an upside breakout; LTBG (Lightbridge Inc)
Consolidating after strong run; BRCD (Brocade Communications
Systems) consolidating strong run; ICLR (Icon PLC) breaking out
on strong earnings report.
Stocks Removed from the Open Active Table
7 stocks saw their 12-month PRS rankings fall and have been
removed from the Open Active Position Table. The most notable
are TIE, which reached our entry criteria on June 2004
and advanced over 1400% during the near three years it held
within our criteria. CECE was profiled in Hotline Update
#10 on 1-16-07 when the stock was trading at $10.25. It reached
our exit criteria on Wednesday the 18th when it
closed at $14, about 35% above its recommendation price.
AVCI recently shot up like a rocket until their earnings
report when they announced serious corporate changes. AVCI will
record an exit price of Tuesday’s close and a gain of nearly
20%. All seven exits this month were for gains.
TIE, CECE, FSYS, VMI, and ZOLT were listed as expected to be
removed from the Open Active Table due to challenging
performance.
*** GYMB, LDSH, CASS, INAP, LQDT, STKL, are on the bubble and
may drop from the Open Active Table over the next one to three
weeks.
Open Actives of Interest
The table below shows the top section of the Open Active
table, which currently has 150 stocks on it. (See April monthly
report for the full list.) Stocks shown are either close to
being removed from our open active table (shown in red) or are
within our entry criteria and shown in green.
Stocks shown in green of interest: CHINA, RBN, AOB,
CHTR, TELN, ZOLL, CNS, JST. Other Open Active
Stocks not shown: ANST, GROW, IAAC, JLL, CVO, WFR, ANAD, NUAN,
AKS (on a pullback), LTBG, IGLD, GSOL, PSMT.
Model Portfolios
ICLR reported earnings of 42¢ vs consensus of 39¢ and the
stock reacted positively.
LVLT (-22¢) and SMSI (17¢) report earnings Thursday after
the close.
We will continue holding LVLT through earnings as it
remains at the $6 support level.
- We are Closing the GHDX position and adding two new longs,
LTBG and JST.
Our second portfolio is a more aggressive portfolio, which
will hold 35 to 45 positions once it is time to get really
aggressive. It is based on a $500,000 initial account value and
was launched on February 13, just two weeks before the market
peaked.
In the aggressive Portfolio, LVLT is viewed the same as in the
conservative Portfolio. TWGP saw its PRS_12 fall below 75 and
it was removed from the open Active Table on April 9. However,
due to the stocks historical tendency to drop briefly we held
the stock and it recovered. Its PRS_12 ranking is once again
back above 75. If it falls below there again we will move on.
- In the Aggressive Portfolio we are making several changes:
- SELL 350 OMX @ 52.03 to close the position.
- SELL 1000 ACGY @ 21.10 to close the position
These changes bring our exposure up near 59%.
Our aggressive portfolio was launched on February 13, 2007 and
we continue building up towards a full portfolio.
The run higher in April has been tremendous and we have
seen a number of our Open Active stocks lead the way higher.
Plus, we saw some very nice earnings reports Tuesday morning
that gave a couple of our favorite stocks a nice lift. Earnings
season continues at a heavy pace for the next few weeks and we
continue to expect solid results. When strong stocks report
great earnings, it is a powerful combination that often results
in new highs.
And if you ever wonder why you ride
the carousel
You do it for the stories you can tell.
Jim Patterson
| It
should not be assumed that recommendations made will be
profitable or will equal the past performance of securities
discussed herein. The information herein is collected from
various sources believed to be reliable but cannot be
guaranteed in any way. Patterson Capital, Inc., Patterson
Relative Strength Report, nor their employees or directors
shall be liable in any manner for losses of any kind. The
firm, its affiliates and their respective offices,
directors, employees and clients may or may not have a
position long or short in stocks mentioned in this
publication and may from time to time increase or decrease
their positions. All performance numbers presented are
hypothetical and do not represent actual trading.
|
|